165 related articles for article (PubMed ID: 12554889)
1. Imbalance between levels of nitrogen oxides and peroxynitrite inhibitory activity in chronic obstructive pulmonary disease.
Kanazawa H; Shiraishi S; Hirata K; Yoshikawa J
Thorax; 2003 Feb; 58(2):106-9. PubMed ID: 12554889
[TBL] [Abstract][Full Text] [Related]
2. Effect of inhaled beclomethasone dipropionate on peroxynitrite inhibitory activity in induced sputum from asthmatic patients.
Kanazawa H; Nomura S; Hirata K; Yoshikawa J
Chest; 2003 Nov; 124(5):1755-61. PubMed ID: 14605045
[TBL] [Abstract][Full Text] [Related]
3. Elevated oxidative stress and reciprocal reduction of vascular endothelial growth factor levels with severity of COPD.
Kanazawa H; Yoshikawa J
Chest; 2005 Nov; 128(5):3191-7. PubMed ID: 16304261
[TBL] [Abstract][Full Text] [Related]
4. Decreased peroxynitrite inhibitory activity in induced sputum in patients with bronchial asthma.
Kanazawa H; Shiraishi S; Hirata K; Yoshikawa J
Thorax; 2002 Jun; 57(6):509-12. PubMed ID: 12037225
[TBL] [Abstract][Full Text] [Related]
5. Correlation of exhaled nitric oxide with nitrogen oxides and selected cytokines in induced sputum of chronic obstructive pulmonary disease patients.
Ziora D; Dworniczak S; Kaczmarczyk G; Jastrzebski D; Krzywiecki A; Kozielski J
J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):791-9. PubMed ID: 18204193
[TBL] [Abstract][Full Text] [Related]
6. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
Xin XF; Zhao M; Li ZL; Song Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
[TBL] [Abstract][Full Text] [Related]
7. Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects.
Beeh KM; Beier J; Kornmann O; Buhl R
Respir Med; 2003 Jun; 97(6):634-9. PubMed ID: 12814147
[TBL] [Abstract][Full Text] [Related]
8. Neutrophilic inflammation and IL-8 levels in induced sputum of alpha-1-antitrypsin PiMZ subjects.
Malerba M; Ricciardolo F; Radaeli A; Torregiani C; Ceriani L; Mori E; Bontempelli M; Tantucci C; Grassi V
Thorax; 2006 Feb; 61(2):129-33. PubMed ID: 16284217
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine.
Barczyk A; Pierzchala W; Sozañska E
Respir Med; 2003 Jun; 97(6):726-33. PubMed ID: 12814161
[TBL] [Abstract][Full Text] [Related]
10. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease.
Hacievliyagil SS; Gunen H; Mutlu LC; Karabulut AB; Temel I
Respir Med; 2006 May; 100(5):846-54. PubMed ID: 16214322
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-18 in induced sputum: association with lung function in chronic obstructive pulmonary disease.
Rovina N; Dima E; Gerassimou C; Kollintza A; Gratziou C; Roussos C
Respir Med; 2009 Jul; 103(7):1056-62. PubMed ID: 19208460
[TBL] [Abstract][Full Text] [Related]
12. Long-term treatment with theophylline reduces neutrophils, interleukin-8 and tumor necrosis factor-alpha in the sputum of patients with chronic obstructive pulmonary disease.
Iiboshi H; Ashitani J; Katoh S; Sano A; Matsumoto N; Mukae H; Nakazato M
Pulm Pharmacol Ther; 2007; 20(1):46-51. PubMed ID: 16413994
[TBL] [Abstract][Full Text] [Related]
13. Exhaled nitric oxide correlated with induced sputum findings in COPD.
Silkoff PE; Martin D; Pak J; Westcott JY; Martin RJ
Chest; 2001 Apr; 119(4):1049-55. PubMed ID: 11296168
[TBL] [Abstract][Full Text] [Related]
14. Expression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patients.
Zhang L; Cheng Z; Liu W; Wu K
COPD; 2013 Aug; 10(4):459-65. PubMed ID: 23537276
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD.
Traves SL; Culpitt SV; Russell RE; Barnes PJ; Donnelly LE
Thorax; 2002 Jul; 57(7):590-5. PubMed ID: 12096201
[TBL] [Abstract][Full Text] [Related]
16. Peroxynitrite elevation in exhaled breath condensate of COPD and its inhibition by fudosteine.
Osoata GO; Hanazawa T; Brindicci C; Ito M; Barnes PJ; Kharitonov S; Ito K
Chest; 2009 Jun; 135(6):1513-1520. PubMed ID: 19188555
[TBL] [Abstract][Full Text] [Related]
17. Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease?
Rahman I; Swarska E; Henry M; Stolk J; MacNee W
Thorax; 2000 Mar; 55(3):189-93. PubMed ID: 10679536
[TBL] [Abstract][Full Text] [Related]
18. Sputum YKL-40 levels and pathophysiology of asthma and chronic obstructive pulmonary disease.
Otsuka K; Matsumoto H; Niimi A; Muro S; Ito I; Takeda T; Terada K; Yamaguchi M; Matsuoka H; Jinnai M; Oguma T; Nakaji H; Inoue H; Tajiri T; Iwata T; Chin K; Mishima M
Respiration; 2012; 83(6):507-19. PubMed ID: 21968467
[TBL] [Abstract][Full Text] [Related]
19. Induced sputum metalloproteinases and their inhibitors in relation to exhaled nitrogen oxide and sputum nitric oxides and other inflammatory cytokines in patients with chronic obstructive pulmonary disease.
Ziora D; Dworniczak S; Kozielski J
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():809-17. PubMed ID: 19218708
[TBL] [Abstract][Full Text] [Related]
20. New developments in the treatment of COPD: comparing the effects of inhaled corticosteroids and N-acetylcysteine.
van Overveld FJ; Demkow U; Górecka D; de Backer WA; Zielinski J
J Physiol Pharmacol; 2005 Sep; 56 Suppl 4():135-42. PubMed ID: 16204787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
